NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
FASTSELECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FASTSELECT
ST13
US500000090551592Class
1, 5
Filing
90551592
Registration
7081302
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/13/2023
Trademark type
Word
Nice classes
1, 5
Filing date
02/28/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
05/26/2020
First use in commerce
05/26/2020
Drawing code
4
Owner type
16
Owner location
Germantown, MD
Examiner
PINO, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Qiagen Sciences, LLC
Representatives
Randolph E. Digges, III RANKIN, HILL & CLARK, LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposesdiagnostic preparations except for human or veterinary medical purposes; non-medical reagentsenzymes and buffer solutions for scientific and/or medical research use; non-medical reagentsenzymes and buffer solutions for molecular biology scientific research applications; non-medical reagentsenzymes and buffer solutions for scientific research use for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and/or for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplification and sequencing; kits for scientific research use comprising chemicals for sample preparationmodification and manipulation of cells; kits for scientific research use comprising chemicals for markingseparatingisolatingpurifyingduplicatingsequencing and/or for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids of biological or biochemical sample material; kits for scientific research use comprising reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplification and sequencing
Class 5
Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposesin particular diagnosticsfor sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and/or for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplification and sequencing; diagnostic chemicalbiochemical and biotechnological preparations for medical and veterinary purposesin particular reagentsenzymes and buffer solutions for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and/or for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplification and sequencing; diagnostic kits containing preparations for medical and veterinary diagnostic purposesin particular for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and/or for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplification and sequencing
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/10/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/28/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/25/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/24/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/07/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/06/2022
IUAF
USE AMENDMENT FILED
09/23/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/23/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/24/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2021
GNRT
NON-FINAL ACTION E-MAILED
09/29/2021
CNRT
NON-FINAL ACTION WRITTEN
09/29/2021
DOCK
ASSIGNED TO EXAMINER
09/22/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/13/2021
ALIE
ASSIGNED TO LIE
07/13/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens FASTSELECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.